Sign in

Jon Lim, FRCP PhD

@drjonlim.bsky.social
2.4K followers 540 following 487 posts

Senior Lecturer & Consultant Medical Oncologist in Advanced #Immunotherapy + #CellTherapy at @manchester.ac.uk & The Christie • RISE Lead & MANIFEST Deputy Lead • ESMO #TranslationalResearch Faculty 🔗 Bio: bit.ly/Christie_JLim (tennis enthusiast 🎾)

PostsRepliesMedia
Reposted by Jon Lim, FRCP PhD
The University of Manchester @manchester.ac.uk · 21/09/2026
The challenges shaping our future need connected thinking. See how our Platforms support collaboration across One University 👇 @uomcreativemcr.bsky.social @digitaluom.bsky.social @healthierfutures.bsky.social @sustainableuom.bsky.social
1113
Reposted by Jon Lim, FRCP PhD
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 18/09/2026
ESMO is pleased to announce the #ESMOAmbassadors for #ESMO26. They will share scientific highlights, expert perspectives and insights on the latest research presented at #ESMO26 across tumour types and disciplines. 🔗Discover the Ambassadors: ow.ly/BQ3i50ZOkEv
042
Jon Lim, FRCP PhD @drjonlim.bsky.social · 09/09/2026
Great to be here in Suzhou 🇨🇳 this week for #CSHAsia Cancer Immunotherapy meeting. Looking forward to learning from colleagues and discussing science 👇
011
Reposted by Jon Lim, FRCP PhD
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 09/09/2026
📣 #ESMO26: Join Prof. James Larkin, Scientific Committee Co-Chair, to exchange perspectives, debate emerging evidence, and discuss the future of cancer prevention, diagnosis, and treatment. ⏰ Late registration deadline: 16 September 2026 🔗 ow.ly/q9GM50ZJcZh #esmomeetings
034
Reposted by Jon Lim, FRCP PhD
The University of Manchester @manchester.ac.uk · 07/08/2026
Welcome, Professor Mahima Swamy! 💜 An internationally recognised researcher in intestinal immunology, Professor Swamy has joined the University of Manchester's Lydia Becker Institute as Professor of Immunology, strengthening its world-class expertise in barrier immunity.
Professor Mahima Swamy
121
Reposted by Jon Lim, FRCP PhD
The University of Manchester @manchester.ac.uk · 18/08/2026
WORLD-LEADING IMMUNOLOGIST TAKES UP TOP UOM ROLE ⬇️🦠 Leading immunologist and cytokine biologist, Prof. Sarah Gaffen has been appointed as the new director of The Lydia Becker Institute of Immunology and Inflammation. Welcome, Sarah! 💫 @lydiabeckeriii.bsky.social
073
Jon Lim, FRCP PhD @drjonlim.bsky.social · 27/08/2026
🎓 Massive congratulations to our fantastic Medical Oncology honorary consultant colleagues at The Christie NHS Foundation Trust on their promotions to 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗖𝗵𝗮𝗶𝗿𝘀 @manchester.ac.uk! 🌟Prof Sacha Howell 🌟Prof Natalie Cook 🌟Prof Colin Lindsay @uom-dcs.bsky.social @mcrcnews.bsky.social
142
Reposted by Jon Lim, FRCP PhD
Caetano Reis e Sousa @reisesousalab.bsky.social · 19/08/2026
Hope you enjoy this short piece, which came out yesterday. Some thoughts I’ve been musing on for a while about why adaptive immunity evolved. Read it for free at rdcu.be/fAO5P
rdcu.be
Why adaptive immunity?
Nature Reviews Immunology - Adaptive immunity is indispensable to vertebrates, yet most living organisms defend themselves perfectly well without it. Here, I ask why somatically diversified antigen...
34416
Jon Lim, FRCP PhD @drjonlim.bsky.social · 03/08/2026
As an early-phase trialist, I never stop being amazed by the bravery & generosity of people who step forward into the unknown. Patients like Tracy don't just shape their own care; they open doors for everyone who follows. 🔬 So it means a great deal to share a 𝗴𝗹𝗼𝗯𝗮𝗹 𝗳𝗶𝗿𝘀𝘁 🌎... @mcrcnews.bsky.social
bbc.co.uk
Oldham woman becomes world's first to receive new cancer therapy
Tracy Tomlinson was offered the clinical trial for ovarian cancer at The Christie hospital in Manchester.
182
Jon Lim, FRCP PhD @drjonlim.bsky.social · 28/07/2026
🚀 A major milestone for @manifest-cirrp.bsky.social. Launching our prospective recruitment represents a significant milestone since we launched in Q4 2024. In doing so, we'll have the opportunity to learn from every patient. @ukri.org @crick.ac.uk 📖 Read more in The Christie press release: 1/4
christie.nhs.uk
Sandbach man is the first in the UK to join landmark immunotherapy study
Mark England was diagnosed with bladder cancer in early December last year. He is the first patient to join the MANIFEST study, one of the largest immunotherapy studies in the country.
112
Jon Lim, FRCP PhD @drjonlim.bsky.social · 26/07/2026
𝗠𝗔𝗡𝗜𝗙𝗘𝗦𝗧 is truly a team effort. 💡 Humbled to hear our very first patient share his perspective. Experiences like his will shape how we scale up & are already helping us learn how more. Watch this space. @manifest-cirrp.bsky.social 📰 As featured today in @theobserveruk.bsky.social 👇
observer.co.uk
‘It won’t help me, but it might help someone like me’ say...
Mark England says numb fingers help him play guitar as researchers hope to change how disease is treated by investigating why immunotherapy does not benefit all
041
Jon Lim, FRCP PhD @drjonlim.bsky.social · 01/07/2026
🔬 Another fantastic 𝗠𝗮𝗻𝗰𝗵𝗲𝘀𝘁𝗲𝗿 𝗜𝗺𝗺𝘂𝗻𝗼-𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗡𝗲𝘁𝘄𝗼𝗿𝗸 (𝗠𝗜𝗢𝗡) meeting! Great to bring together colleagues from academia, NHS & industry to showcase Manchester-led immuno-oncology research, celebrate recent presentations at major international 🌍 conferences. @mcrcnews.bsky.social
152
Reposted by Jon Lim, FRCP PhD
Magnus Rattray @mrattray.bsky.social · 17/06/2026
Exciting times in Manchester. Major investment in the CRUK Manchester Institute with eight new groups, including new group leader positions in computational biology and AI www.cruk.manchester.ac.uk/about/new-fu... @cruk-mi.bsky.social
cruk.manchester.ac.uk
Major New Funding For Our Cancer Research | Cancer Research UK Manchester Institute
0113
Reposted by Jon Lim, FRCP PhD
Justin Loke @jloke1.bsky.social · 27/06/2026
Engineer blood cancer to defeat it!👨‍🔬👩‍🔬 I'm hiring a Senior Scientific Officer at the CRUK Manchester Institute — using CRISPR to recreate the mutation combinations behind AML and MDS, and find where they're vulnerable. Hands-on. Apply 👇 @cruk-mi.bsky.social apps.cruk.manchester.ac.uk/recruitment/...
0108
Jon Lim, FRCP PhD @drjonlim.bsky.social · 26/06/2026
A great collaboration 🙌 between our Thoracic Oncology, and Advanced Immunotherapy and Cell Therapy teams at The Christie 🐝 - driven by our stellar Senior Clinical Research Fellows Federico Monaca and Rachel Woodford. Available #OpenAccess in 𝘛𝘩𝘦𝘳 𝘈𝘥𝘷 𝘔𝘦𝘥 𝘖𝘯𝘤𝘰𝘭 👇 @christielibrary.bsky.social
142
Jon Lim, FRCP PhD @drjonlim.bsky.social · 25/06/2026
🚀 We're building momentum with our RISE programme, and growing our team! Come join us as a 𝗧𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗧𝗲𝗰𝗵𝗻𝗶𝗰𝗶𝗮𝗻. Deadline 7th July 2026 👇 @uom-dcs.bsky.social @fbmh-uom.bsky.social @mcrcnews.bsky.social
jobs.manchester.ac.uk
Translational Research Technician:Paterson Building
020
Jon Lim, FRCP PhD @drjonlim.bsky.social · 24/06/2026
Great to be in Porto 🇵🇹 for ASPIC International Congress. Looking forward to 2 days of science! Slightly shameless plug: if you’re interested in PhD, postdoc, clinician-scientist, group leader or Clinical Research Fellowship opportunities in Manchester, come say hello 👋 - I’d be happy to chat.
000
Jon Lim, FRCP PhD @drjonlim.bsky.social · 22/06/2026
🧑‍🔬 Postdoc position available in our MRC-funded RISE team - Valletta/Lim. The successful candidate will lead a translational project using CODEX multiplex imaging to study CRS pathogenesis in bone marrow from CAR-T patients - working with clinicians, scientists & industry. Deadline 10 July👇
jobs.manchester.ac.uk
Research Associate:Oglesby Cancer Research Building, 555 Wilmslow Road, M20 4GJ
111
Jon Lim, FRCP PhD @drjonlim.bsky.social · 21/06/2026
Featured on BBC News: #TeamManchester is growing. 🚀 Cancer Research UK Manchester Institute will be receiving an extra £6m a year in investment, creating 8️⃣ senior research roles: 4 group leaders, 2 senior group leaders & 2 clinician scientists. @cruk-mi.bsky.social www.bbc.co.uk/news/article...
bbc.co.uk
Manchester cancer research lab's £6m extra annual cash boost
Cancer Research UK Manchester Institute says the extra cash will make a "huge difference" to its work.
186
Jon Lim, FRCP PhD @drjonlim.bsky.social · 20/06/2026
🚀 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗙𝗲𝗹𝗹𝗼𝘄𝘀𝗵𝗶𝗽 opportunities - come join us in Manchester! Looking to develop your career in Oncology? Interested in building a subspecialty interest? Keen to combine clinical excellence with research? Several exciting opportunities available at The Christie NHS Foundation Trust 👇
141
Reposted by Jon Lim, FRCP PhD
Manchester Cancer Research Centre @mcrcnews.bsky.social · 17/06/2026
How do donated tissue samples help shape future cancer treatments? Our latest blog explores the work of the MCRC Biobank, which has collected more than 230,000 samples from nearly 30,000 patients to support cutting-edge cancer research. Read more: ow.ly/ozuS50Z5EsS
ow.ly
The MCRC Biobank: Turning Tissue Donations into Tomorrow's Treatments - Manchester Cancer Research Centre
Every year, thousands of cancer patients treated at The Christie NHS Foundation Trust, Manchester University NHS Foundation Trust and Northern Care Alliance NHS Foundation Trust choose to donate tissue samples to the Manchester Cancer Research Centre Biobank.
045
Jon Lim, FRCP PhD @drjonlim.bsky.social · 07/06/2026
Almost 2️⃣ years in… Our MANIFEST AGM convened scientists, clinicians, patient partners & industry. Keynotes from Prof Levesque & Prof Rattray + Prof Turajlić setting the course ahead. Big thank you to all for continuing to believe in the vision; to tackle the hard questions in #CancerImmunotherapy.
0103
Jon Lim, FRCP PhD @drjonlim.bsky.social · 20/05/2026
💥 Really pleased to see this story finally out in @natcancer.nature.com. An elegant study built around a very cool concept. Huge congratulations to Tom Castro-Dopico, @reisesousalab.bsky.social and all colleagues involved - delighted to have played a small part in it the journey. @crick.ac.uk
052
Reposted by Jon Lim, FRCP PhD
Caetano Reis e Sousa @reisesousalab.bsky.social · 29/04/2026
Nice celebration @reisesousalab.bsky.social of our recently published or in press papers. L-R: Tom Castro-Dopico, Oliver Schulz, @drjonlim.bsky.social and Mike Buck. See earlier and forthcoming posts for paper details.
1111
Reposted by Jon Lim, FRCP PhD
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 22/04/2026
🚨 We're looking for an Associate Director for Strategy & Partnerships — a pivotal leadership role that will help define how we connect, collaborate, and amplify our impact on a global stage of cancer research! Apply below by 26.05.2026! 👇 www.cruk.manchester.ac.uk/career/mi-26... Salary - ~£80,000
094
Jon Lim, FRCP PhD @drjonlim.bsky.social · 18/04/2026
Fantastic 2 days in San Diego 🌴 for the inaugural C8 Early Career Investigators Symposium. Happy to represent #TeamManchester + connect with an inspiring group 🌍. A reminder that we’re not navigating academia alone - great to hear re: lessons learned & tips for future 🤝. @mcrcnews.bsky.social
062
Reposted by Jon Lim, FRCP PhD
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 15/04/2026
#ESMOTAT26: Drug development in oncology is increasingly moving towards integrated strategies that consider tumour cells, their microenvironment and anatomical context. Read the Opinion by Jon Lim, FRCP PhD in the #ESMODailyReporter 📌 ow.ly/fFUx50YJxOP
032
Reposted by Jon Lim, FRCP PhD
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 13/04/2026
🚨 Open for applications - Director of Scientific Core Facilities & Services! Shape the strategic future of our core facilities and work with leading experts on cutting-edge cancer discovery and translational research 🧑‍🔬🔬🧪 💷 ~£100,000 ⏰ 17.5.2026 Apply 👉 www.cruk.manchester.ac.uk/career/mi-26...
A collage of images show imaging technologies, stained cells and a mouse in a specially designed research habitat
044
Jon Lim, FRCP PhD @drjonlim.bsky.social · 10/04/2026
Tumour infiltrating lymphocyte (TIL) therapy is here to stay...but toxicity may be the real bottleneck. Most of it is not the TILs - it’s everything around them. We unpack this in our latest review. Available #OpenAccess - 𝘑 𝘐𝘮𝘮𝘶𝘯𝘰𝘛𝘩𝘦𝘳 𝘊𝘢𝘯𝘤𝘦𝘳 @sitcancer.bsky.social👇 🔗 jitc.bmj.com/content/14/4...
042
Reposted by Jon Lim, FRCP PhD
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 02/04/2026
We're thrilled to see our Director, Samra Turajlić be awarded the Kidney Cancer Association Pieter De Mulder award for contributions towards the treatment of kidney cancer 🎉 Samra's research group is investigating how and why kidney cancer evolves to increase the success of treatment strategies 🧪
CRUK MI Director Samra Turaljic superimposed over an image of renal cell carcinoma cells stained with a fluorescenet dye.
1111
Jon Lim, FRCP PhD @drjonlim.bsky.social · 26/03/2026
🚀 We’re hiring: 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗣𝗿𝗼𝗷𝗲𝗰𝘁 𝗠𝗮𝗻𝗮𝗴𝗲𝗿 𝗶𝗻 𝗜𝗺𝗺𝘂𝗻𝗼-𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 An exciting 🆕 role which sits at the heart of a highly collaborative & ambitious ecosystem spanning the Manchester Immuno-Oncology Network (MION) + the Advanced Immunotherapy and Cell Therapy (AICT) programme. 📩 Deadline 9th April 2026.
apps.trac.jobs
Research Project Manager | Job advert | Trac
021
Reposted by Jon Lim, FRCP PhD
Tim @timisstuck.bsky.social · 29/01/2026
Next, master of dendritic cells Caetano has an update on dead cell recognition in the context of tumor immunity: We knew DC use exposed actin to gobble up dead cells. Here they show if you tether a model tumor antigen to actin, you get better anti-tumor immunity. Neat!!! doi.org/10.1038/s415...
doi.org
Cross-presentation of dead cell-associated antigens shapes the neoantigenic landscape of tumor immunity - Nature Immunology
Here the authors show DNGR-1 expressed by cDC1s promotes CD8⁺ T cell priming to cytoskeletal neoantigens from dying tumor cells, thereby shaping cancer immune visibility and tumor evolution through im...
131
Jon Lim, FRCP PhD @drjonlim.bsky.social · 20/03/2026
Cell therapy for solid tumours is advancing rapidly, but translation into patient benefit will depend on continued collaboration 🌍. 💡 Delighted to see this work come to fruition - thanks to all co-authors, for this thoughtful & collaborative effort. @haanenjohn.bsky.social #OpenAccess 👇
thelancet.com
Advances in cell therapy for solid tumours: European perspective and future directions
Cell therapy has revolutionised the landscape of cancer treatment, with therapies such as Chimeric Antigen Receptor T cells (CAR-T cells), showing remarkable efficacy in haematological malignancies, a...
031
Reposted by Jon Lim, FRCP PhD
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 17/03/2026
Exciting new research from our Group Leader @sylvaindelaunay.bsky.social and Pierre Close at @universitedeliege.bsky.social shows how modifying a tRNA can alter the immune profile of #melanoma - exposing it to the #ImmuneSystem Read the full story here: www.cruk.manchester.ac.uk/news/new-res...
cruk.manchester.ac.uk
New Research: TRNA Modification Triggers Anti-tumour Immunity | Cancer Research UK Manchester Institute
New research has uncovered an unexpected way to stimulate the immune system against cancer: by subtly disrupting how tumour cells manufacture their proteins.
064
Reposted by Jon Lim, FRCP PhD
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 05/03/2026
We have three exciting opportunities for you to join us for a fully-funded 4-year #PhD project here in #Manchester starting in October 2026 Find full details of all the projects on our website: www.cruk.manchester.ac.uk/phd-student-... Applications close 3rd April 2026
055
Jon Lim, FRCP PhD @drjonlim.bsky.social · 13/03/2026
Fantastic inaugural national TIL Therapy Summit in Manchester with a stellar faculty ⭐. Great to welcome colleagues from across the UK & Europe for a day full of insightful discussions on the current landscape + future of TIL therapy. @mcrcnews.bsky.social
133
Reposted by Jon Lim, FRCP PhD
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 06/03/2026
Do you have an impactful research idea? One that could improve care or advance science? Apply for the ESMO Leadership & Career Development Award, offering protected research time, leadership & communication training by 3 May 26 . 🔗https://ow.ly/Gicm50YqcbZ #Oncology #ESMOYOC
156
Jon Lim, FRCP PhD @drjonlim.bsky.social · 04/03/2026
The Crick Postdoctoral Clinical Fellowship has been one of the most pivotal steps in my development as a clinical academic. The environment, mentorship, infrastructure, and scientific ambition at @crick.ac.uk are truly unparalleled. Strongly recommended! Deadline: 30th April 👇
000
Jon Lim, FRCP PhD @drjonlim.bsky.social · 25/02/2026
Grateful to 𝘉𝘳 𝘑 𝘊𝘢𝘯𝘤𝘦𝘳 for the kind feature in their 𝗘𝗺𝗲𝗿𝗴𝗶𝗻𝗴 𝗟𝗲𝗮𝗱𝗲𝗿𝘀 collection. Thank you to the editors for the nomination 🙏. Like many things, this really reflects teamwork & collaboration with many generous colleagues. Our perspective on TIL therapy in melanoma is now out #OpenAccess 👇
nature.com
Emerging Leaders | Emerging Leaders - British Journal of Cancer
BJC’s Emerging Leaders collection recognises stand-out early-to-mid career researchers, clinicians, and educators within the field of oncology.
141
Reposted by Jon Lim, FRCP PhD
Manchester Cancer Research Centre @mcrcnews.bsky.social · 25/02/2026
Professor Ludwig Dubois joins the MCRC & @manchester.ac.uk @fbmh-uom.bsky.social as Chair in Experimental & Translational Radiobiology. He’ll spearhead research into proton beam therapy & FLASH treatments to improve patient outcomes. Read more: ow.ly/1k5g50YkUEn
Man in a dark blue patterned shirt leaning on a window ledge inside a bright, modern corridor with large windows.
021
Jon Lim, FRCP PhD @drjonlim.bsky.social · 19/02/2026
Our new perspective just out in 𝘉𝘳𝘪 𝘑 𝘊𝘢𝘯𝘤𝘦𝘳 on TIL therapy in melanoma. As TIL move closer to real-world use, the 𝘩𝘰𝘸 matters as much as the 𝘸𝘩𝘦𝘵𝘩𝘦𝘳. We reflect on the near future & the practical challenges of moving from trials to routine care. Keen to hear thoughts/experiences from others👇
nature.com
Tumour-infiltrating lymphocyte therapy in melanoma: ready for prime time? - British Journal of Cancer
British Journal of Cancer - Tumour-infiltrating lymphocyte therapy in melanoma: ready for prime time?
021
Reposted by Jon Lim, FRCP PhD
Natalie Cook @oncocook.bsky.social · 17/02/2026
Come and join us at the ESMO Preceptorship on CUP! @worldcupalliance.bsky.social spread the word!
082
Jon Lim, FRCP PhD @drjonlim.bsky.social · 07/02/2026
🎓 New PhD Opportunity An exciting PhD opportunity at the Cancer Research UK Manchester Centre, supporting the next generation of leaders in cancer research. 📅 Deadline: Friday 3 April 🔗 For further information & to apply: ow.ly/ZWYs50Y7vHR @uom-dcs.bsky.social @manchester.ac.uk
021
Jon Lim, FRCP PhD @drjonlim.bsky.social · 03/02/2026
📣 Final agenda confirmed - only 5 weeks to go! Join us on 𝟭𝟭 𝗠𝗮𝗿𝗰𝗵 𝟮𝟬𝟮𝟲 in Manchester 🐝 for our inaugural TIL Summit: Unlocking TIL Therapy – A New Era for Melanoma Care in the UK. Kindly sponsored by The Christie Charity. Space limited - so don't miss out! For further information & to register:
christie.nhs.uk
Unlocking TIL Therapy: A New Era for Melanoma Care in the UK
TIL (Tumour-Infiltrating Lymphocyte) therapy is a transformative, cell-based immunotherapy approach now entering clinical practice for melanoma. This national summit brings together UK and internation...
154
Jon Lim, FRCP PhD @drjonlim.bsky.social · 02/02/2026
One of the projects I’m most proud of since returning to Manchester. In awe of the resilience of our Ukrainian colleagues delivering cancer care under extraordinary circumstances, and grateful for the generosity of #TeamManchester colleagues in sharing best practice. 🇬🇧 🤝 🇺🇦 Find out more 👇
christie.nhs.uk
The beginning of an international partnership between The Christie and the National Cancer Institute of Ukraine
The Christie Institute for Cancer Education has welcomed international colleagues from the National Cancer Institute of Ukraine (UNCI) as part of a new education partnership focused on bilateral shari...
021
Reposted by Jon Lim, FRCP PhD
Society for Immunotherapy of Cancer @sitcancer.bsky.social · 26/01/2026
New Journal for ImmunoTherapy of Cancer review: Steroid-sparing strategies for managing immune-related adverse events jitc.bmj.com/content/14/1...
021
Reposted by Jon Lim, FRCP PhD
Becki Lee @beckilee.bsky.social · 22/01/2026
Exciting conference alert! sites.manchester.ac.uk/from-lab-to-... Fantastic speakers including Chris Marine, Christian Blank Melanoma evolution Local microenvironment of melanoma Melanoma-host interactions Precision immunotherapy Emerging therapeutics Clinical trials and real-world data
lab to life
075
Jon Lim, FRCP PhD @drjonlim.bsky.social · 22/01/2026
🆕 New on the ESMO events calendar for 2026! Mark your calendar for the 𝗘𝗦𝗠𝗢 𝗣𝗿𝗲𝗰𝗲𝗽𝘁𝗼𝗿𝘀𝗵𝗶𝗽 𝗼𝗻 𝗧𝘂𝗺𝗼𝘂𝗿-𝗔𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗖𝗮𝗻𝗰𝗲𝗿𝘀 𝗮𝗻𝗱 𝗖𝗮𝗻𝗰𝗲𝗿 𝗼𝗳 𝗨𝗻𝗸𝗻𝗼𝘄𝗻 𝗣𝗿𝗶𝗺𝗮𝗿𝘆 (𝗖𝗨𝗣) in Zurich: 18-19 September 2026. Chaired by the fantastic @oncocook.bsky.social & @benwestphalen.bsky.social. @myesmo.bsky.social
130
Jon Lim, FRCP PhD @drjonlim.bsky.social · 18/01/2026
This is one of the projects I’m most proud of since coming back to (re-)join #TeamManchester faculty. Delighted to welcome and host our Medical Oncology colleagues from UNCI, Kyiv at The Christie. 🇺🇦 🤝 🇬🇧
052
Jon Lim, FRCP PhD @drjonlim.bsky.social · 15/01/2026
🚀 Kicking off the new year with our next #ChristieFellowship session! How do we communicate science well - to patients, the public, and on social media? Join us for an interactive session on 𝗣𝘂𝗯𝗹𝗶𝗰 𝗖𝗼𝗺𝗺𝘂𝗻𝗶𝗰𝗮𝘁𝗶𝗼𝗻 with Prof @achoud72.bsky.social. @christieinstitute.bsky.social @mcrcnews.bsky.social
053